Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
PMID: 21950636
o On Day 61 or thereafter, if: No additional glycemic control is needed maintain the dosage at 4 mg orally once daily
Regulatory Status Disclosure: The FDA declared the semaglutide drug shortage resolved in February 2025 and the tirzepatide drug shortage resolved in October 2024
While its true that these medications originated as treatments for type 2 diabetes and pre-diabetes, both semaglutide and tirzepatide are also FDA-approved to treat obesity
Nat Rev Immunol 21(11):739751
Telemedicine options exist but vary by province, and not all physicians are comfortable prescribing weight loss medications
US$ 21.50
US$ 26.79
US$ 25.10
US$ 27.72
US$ 25.49
